A novel telomerase-specific gene therapy: Gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter

Shoji Koga, Satoshi Hirohata, Yasuko Kondo, Tadashi Komata, Masahiro Takakura, Masaki Inoue, Saturo Kyo, Seiji Kondo

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Apoptosis is a genetically encoded cell death process and is a pathway that may be disrupted in tumor cells. Therefore, therapies that restore the ability to undergo apoptosis are promising for the treatment of tumor cells. We have demonstrated that the transfer of apoptosis-inducible genes inhibits the growth of tumors in vitro and in vivo through induction of apoptosis. However, to restrict induction of apoptosis to tumor cells, we need to explore a tumor-specific expression system of these genes. In the present study, we developed the telomerase-specific transfer system of apoptosis- inducible genes, utilizing the promoter of the human telomerase catalytic subunit (hTERT) gene. Approximately 90% of tumors have telomerase activity whereas most normal cells do not express the activity. These observations indicate that telomerase is a particularly attractive target for the tumor- specific expression system of vectors. We demonstrate here that by using the hTERT promoter-driven caspase-8 expression vector (hTERT/caspase-8), apoptosis is restricted to telomerase-positive tumor cells of wide range, and is not seen in normal fibroblast cells without telomerase activity. Furthermore, treatment of subcutaneous tumors in nude mice with the hTERT/caspase-8 construct inhibited tumor growth significantly because of induction of apoptosis (p <0.01). The telomerase-specific expression of apoptosis-inducible genes afforded by the hTERT promoter, therefore, may be a novel and promising targeting approach for the treatment of tumors with telomerase activity.

Original languageEnglish
Pages (from-to)1397-1406
Number of pages10
JournalHuman Gene Therapy
Volume11
Issue number10
DOIs
Publication statusPublished - Jul 1 2000
Externally publishedYes

Fingerprint

Telomerase
Genetic Therapy
Apoptosis
Genes
Neoplasms
Caspase 8
human CASP8 protein
Growth
Nude Mice
Cell Death
Therapeutics
Fibroblasts
Gene Expression

ASJC Scopus subject areas

  • Genetics

Cite this

A novel telomerase-specific gene therapy : Gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter. / Koga, Shoji; Hirohata, Satoshi; Kondo, Yasuko; Komata, Tadashi; Takakura, Masahiro; Inoue, Masaki; Kyo, Saturo; Kondo, Seiji.

In: Human Gene Therapy, Vol. 11, No. 10, 01.07.2000, p. 1397-1406.

Research output: Contribution to journalArticle

Koga, Shoji ; Hirohata, Satoshi ; Kondo, Yasuko ; Komata, Tadashi ; Takakura, Masahiro ; Inoue, Masaki ; Kyo, Saturo ; Kondo, Seiji. / A novel telomerase-specific gene therapy : Gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter. In: Human Gene Therapy. 2000 ; Vol. 11, No. 10. pp. 1397-1406.
@article{99f3ecccdc554df0a3f742a3b56fe101,
title = "A novel telomerase-specific gene therapy: Gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter",
abstract = "Apoptosis is a genetically encoded cell death process and is a pathway that may be disrupted in tumor cells. Therefore, therapies that restore the ability to undergo apoptosis are promising for the treatment of tumor cells. We have demonstrated that the transfer of apoptosis-inducible genes inhibits the growth of tumors in vitro and in vivo through induction of apoptosis. However, to restrict induction of apoptosis to tumor cells, we need to explore a tumor-specific expression system of these genes. In the present study, we developed the telomerase-specific transfer system of apoptosis- inducible genes, utilizing the promoter of the human telomerase catalytic subunit (hTERT) gene. Approximately 90{\%} of tumors have telomerase activity whereas most normal cells do not express the activity. These observations indicate that telomerase is a particularly attractive target for the tumor- specific expression system of vectors. We demonstrate here that by using the hTERT promoter-driven caspase-8 expression vector (hTERT/caspase-8), apoptosis is restricted to telomerase-positive tumor cells of wide range, and is not seen in normal fibroblast cells without telomerase activity. Furthermore, treatment of subcutaneous tumors in nude mice with the hTERT/caspase-8 construct inhibited tumor growth significantly because of induction of apoptosis (p <0.01). The telomerase-specific expression of apoptosis-inducible genes afforded by the hTERT promoter, therefore, may be a novel and promising targeting approach for the treatment of tumors with telomerase activity.",
author = "Shoji Koga and Satoshi Hirohata and Yasuko Kondo and Tadashi Komata and Masahiro Takakura and Masaki Inoue and Saturo Kyo and Seiji Kondo",
year = "2000",
month = "7",
day = "1",
doi = "10.1089/10430340050057477",
language = "English",
volume = "11",
pages = "1397--1406",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

TY - JOUR

T1 - A novel telomerase-specific gene therapy

T2 - Gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter

AU - Koga, Shoji

AU - Hirohata, Satoshi

AU - Kondo, Yasuko

AU - Komata, Tadashi

AU - Takakura, Masahiro

AU - Inoue, Masaki

AU - Kyo, Saturo

AU - Kondo, Seiji

PY - 2000/7/1

Y1 - 2000/7/1

N2 - Apoptosis is a genetically encoded cell death process and is a pathway that may be disrupted in tumor cells. Therefore, therapies that restore the ability to undergo apoptosis are promising for the treatment of tumor cells. We have demonstrated that the transfer of apoptosis-inducible genes inhibits the growth of tumors in vitro and in vivo through induction of apoptosis. However, to restrict induction of apoptosis to tumor cells, we need to explore a tumor-specific expression system of these genes. In the present study, we developed the telomerase-specific transfer system of apoptosis- inducible genes, utilizing the promoter of the human telomerase catalytic subunit (hTERT) gene. Approximately 90% of tumors have telomerase activity whereas most normal cells do not express the activity. These observations indicate that telomerase is a particularly attractive target for the tumor- specific expression system of vectors. We demonstrate here that by using the hTERT promoter-driven caspase-8 expression vector (hTERT/caspase-8), apoptosis is restricted to telomerase-positive tumor cells of wide range, and is not seen in normal fibroblast cells without telomerase activity. Furthermore, treatment of subcutaneous tumors in nude mice with the hTERT/caspase-8 construct inhibited tumor growth significantly because of induction of apoptosis (p <0.01). The telomerase-specific expression of apoptosis-inducible genes afforded by the hTERT promoter, therefore, may be a novel and promising targeting approach for the treatment of tumors with telomerase activity.

AB - Apoptosis is a genetically encoded cell death process and is a pathway that may be disrupted in tumor cells. Therefore, therapies that restore the ability to undergo apoptosis are promising for the treatment of tumor cells. We have demonstrated that the transfer of apoptosis-inducible genes inhibits the growth of tumors in vitro and in vivo through induction of apoptosis. However, to restrict induction of apoptosis to tumor cells, we need to explore a tumor-specific expression system of these genes. In the present study, we developed the telomerase-specific transfer system of apoptosis- inducible genes, utilizing the promoter of the human telomerase catalytic subunit (hTERT) gene. Approximately 90% of tumors have telomerase activity whereas most normal cells do not express the activity. These observations indicate that telomerase is a particularly attractive target for the tumor- specific expression system of vectors. We demonstrate here that by using the hTERT promoter-driven caspase-8 expression vector (hTERT/caspase-8), apoptosis is restricted to telomerase-positive tumor cells of wide range, and is not seen in normal fibroblast cells without telomerase activity. Furthermore, treatment of subcutaneous tumors in nude mice with the hTERT/caspase-8 construct inhibited tumor growth significantly because of induction of apoptosis (p <0.01). The telomerase-specific expression of apoptosis-inducible genes afforded by the hTERT promoter, therefore, may be a novel and promising targeting approach for the treatment of tumors with telomerase activity.

UR - http://www.scopus.com/inward/record.url?scp=0034235413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034235413&partnerID=8YFLogxK

U2 - 10.1089/10430340050057477

DO - 10.1089/10430340050057477

M3 - Article

C2 - 10910137

AN - SCOPUS:0034235413

VL - 11

SP - 1397

EP - 1406

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 10

ER -